In Vitro and In Vivo Activity of a Synthetic Halogenated Quinoline Against Cryptococcus neoformans
AUTOR(ES)
Hubbard, J. C.
RESUMO
The minimum inhibitory concentrations of a halogenated quinoline, 3-amino-7-chloro-3,4-dihydro-1-hydroxycarbostyril (CBS), against nine clinical strains of Cryptococcus neoformans were determined by in vitro testing. The CBS was fungistatic at a minimum concentration of 0.2 μg/ml at 48 h for several strains. In vivo toxicity studies were carried out in mice. Mice were also infected with C. neoformans strain Price and injected with various concentrations of CBS. Mean life expectancy of treated groups of animals was increased over infected untreated controls.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=352581Documentos Relacionados
- In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
- In Vitro and In Vivo Efficacies of the New Triazole Albaconazole against Cryptococcus neoformans
- In Vitro and In Vivo Efficacy of the Triazole TAK-187 against Cryptococcus neoformans
- Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro.
- Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro.
